How to Buy Day One Biopharmaceuticals Stock
Day One Biopharmaceuticals Inc
Day One Biopharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers.
Day One Biopharmaceuticals stock last closed at $7.14, up 4.39% from the previous day, and has decreased 53.58% in one year. It has overperformed other stocks in the Biotechnology industry by 0.24 percentage points. Day One Biopharmaceuticals stock is currently +11.39% from its 52-week low of $6.41, and -60.49% from its 52-week high of $18.07.
At the moment, there are 101.35M DAWN shares outstanding. The market cap of DAWN is $723.67M. In the past 24 hours, 1.94M DAWN shares were traded.
How to Buy Day One Biopharmaceuticals Stock
Wondering how to invest in Day One Biopharmaceuticals stock? Here's how.
- Decide where to buy Day One Biopharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you determine where to buy Day One Biopharmaceuticals stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Choose your payment method and add your details.
- Analyze Day One Biopharmaceuticals stock: The Day One Biopharmaceuticals ticker symbol is DAWN. Is Day One Biopharmaceuticals stock a good investment? Should you buy shares of DAWN? How do DAWN's underlying business fundamentals look? Do top analysts think Day One Biopharmaceuticals is a good buy? Why has DAWN's stock price moved recently? (Hint: Our stock research tools can help you understand if DAWN is a good stock to buy).
- Place your DAWN trade: Decide if you will purchase DAWN shares at the current market price or use a limit order to buy DAWN stock at a particular price.
- Monitor your investment in DAWN: Create a watchlist to keep track of your position in Day One Biopharmaceuticals stock.
Step 1: Decide where to buy Day One Biopharmaceuticals stock
You will need a brokerage account to access the NASDAQ market and buy DAWN shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Technology to Utilities, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've picked the right brokerage, it's time to fill out some personal info so you are able to invest in DAWN stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start your new trading account.
- Send your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have filled out your info on the best stock trading app, you need to deposit funds:
Watch the video below if you need help depositing money into your brokerage account.
Step 4: Analyze Day One Biopharmaceuticals stock
Once you have decided on the best place to buy Day One Biopharmaceuticals stock, it's crucial to research their stock prior to investing, so you can wrap your head around the risk and opportunity.
Day One Biopharmaceuticals Numbers
DAWN Due Diligence Checks
WallStreetZen was created to help average investors do more accurate fundamental analysis.
You can see all of the due diligence checks on DAWN's stock page.
What is the fair value of DAWN stock?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge DAWN's fair value.
Using relative valuations methods:
- DAWN may be undervalued based on its P/B ratio of 1.44x, relative to Biotechnology industry P/B ratio of 4.04x
You can do more valuation research on DAWN's stock here.
DAWN Financial Summary
Positive Financial Indicators:
- Total DAWN debt is lower than 5 years ago, relative to shareholder equity.
- DAWN has a low debt to equity ratio of 0.16.
- There are more short-term assets than long-term liabilities on the DAWN balance sheet.
- There are more short-term assets than short-term liabilities on the DAWN balance sheet.
Negative Financial Indicators:
- DAWN earnings of -$88.35M is not sufficient to cover its interest payments.
- DAWN's operating cash flow of -$78.11M allows it to safely service it's debt of $2.60M.
- DAWN profit margin has gone down from N/A to -72.8% in the past year.
Is it a good time to buy Day One Biopharmaceuticals stock, according to Wall Street analysts?
Out of 6 sell side analysts who track DAWN, the consensus analyst rating on DAWN is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent DAWN Analyst Upgrades/Downgrades
Alec Stranahan, a bottom 5% analyst from Bank of America maintains DAWN with a strong buy rating and lowers their DAWN price target from $28.00 to $25.00, on Jan 7, 2025.
An analyst from Jones Trading maintains DAWN with a strong buy rating and lowers their DAWN price target from $39.00 to $34.00, on Dec 17, 2024.
You can dive deeper into what analysts are saying on the Day One Biopharmaceuticals stock forecast page.
DAWN Trading Indicators
Latest Insiders Trades at DAWN
In the past 12 months, insiders at DAWN have sold more shares than they have bought.
Jeremy Bender, CHIEF EXECUTIVE OFFICER of DAWN, was the latest DAWN insider to sell. They sold $144,130.22 worth of DAWN shares on Feb 18, 2025.
Learn more about who owns DAWN shares here.
Can I rely on DAWN as an income stream?
No, Day One Biopharmaceuticals doesn't provide an income stream by paying out dividends.
What do other traders have to say about DAWN?
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your DAWN trade
There are two main order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally the best for newer investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at an exact price limit, use a limit order.
Press the Open button and eToro will place the order.
If you want more help buying stocks on eToro, watch the how to video below:
Step 6: Monitor your investment in DAWN
Now that you own some DAWN shares, you'll want to keep up with your new stock purchase.
Add DAWN to a watchlist to monitor your DAWN stock.
DAWN Feed
How to Buy Stock in Day One Biopharmaceuticals
To summarize, here are the 6 steps for buying Day One Biopharmaceuticals stock:
- Decide where to buy Day One Biopharmaceuticals stock
- Open your brokerage account
- Deposit money your investment account
- Analyze Day One Biopharmaceuticals stock
- Place your DAWN trade
- Monitor your investment in DAWN
If you need a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Day One Biopharmaceuticals, add DAWN to your watchlist by clicking the button below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.